Reduction in Ventricular Tachyarrhythmia Burden in Patients Enrolled in the RAID Trial

The RAID (Ranolazine Implantable Cardioverter-Defibrillator) randomized placebo-controlled trial showed that ranolazine treatment was associated with reduction in recurrent ventricular tachycardia (VT) requiring appropriate implantable cardioverter-defibrillator (ICD) therapy. This study aimed to id...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	JACC. Clinical electrophysiology 2022-06, Vol.8 (6), p.754-762
Hauptverfasser:	Younis, Arwa, Goldenberg, Ilan, Farooq, Shamroz, Yavin, Hagai, Daubert, James, Raitt, Merritt, Mazur, Alexander, Huang, David T., Mitchell, Brent L., Rashtian, Mayer R., Winters, Stephen, Vloka, Margot, Aktas, Mehmet, Bernabei, Matthew A., Beck, Christopher A., McNitt, Scott, Zareba, Wojciech
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged arrhythmia cardioverter-defibrillator Defibrillators, Implantable Humans ICD ranolazine Ranolazine - therapeutic use Tachycardia, Ventricular - prevention & control ventricular tachycardia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!